Literature DB >> 14215062

A CLINICAL TRIAL OF ANTAZOLINE IN THE TREATMENT OF ARRHYTHMIAS.

E W REYNOLDS, W M BAIRD, M E CLIFFORD.   

Abstract

Entities:  

Keywords:  ANTIHISTAMINICS; ARRHYTHMIA; AURICULAR FIBRILLATION; AURICULAR FLUTTER; CORONARY DISEASE; DRUG THERAPY; ELECTROCARDIOGRAPHY; EXTRASYSTOLE; HEART DISEASES; PROCAINE AMIDE; QUINIDINE; RHEUMATIC HEART DISEASE; TACHYCARDIA, PAROXYSMAL; TOXICOLOGIC REPORT; VENTRICULAR FIBRILLATION

Mesh：

Substances：

Year:  1964        PMID： 14215062     DOI： 10.1016/0002-9149(64)90035-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).

Authors:  Michal M Farkowski; Aleksander Maciag; Ilona Kowalik; Marek Konka; Hanna Szwed; Mariusz Pytkowski
Journal:  Br J Clin Pharmacol       Date:  2019-05-23       Impact factor: 4.335

2.  Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter.

Authors:  R Mendez; E Kabela; G Pastelin; M Martínez-López; S Sánchez-Pérez
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

Review 3.  Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Authors:  Omar F Hassan; Jassim Al Suwaidi; Amar M Salam
Journal:  J Atr Fibrillation       Date:  2013-06-30

4.  Antazoline-insights into drug-induced electrocardiographic and hemodynamic effects: Results of the ELEPHANT II substudy.

Authors:  Roman Piotrowski; Joanna Giebułtowicz; Jakub Baran; Agnieszka Sikorska; Dagmara Gralak-Łachowska; Małgorzata Soszyńska; Piotr Wroczyński; Piotr Kułakowski
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-25       Impact factor: 1.468

5.  Antazoline in the treatment of cardiac arrhythmias.

Authors:  S S Shah; C H Vaidya; H V Doshi
Journal:  Postgrad Med J       Date:  1972-05       Impact factor: 2.401

6.  Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart.

Authors:  Bartłomiej Jacek Bińkowski; Marcin Makowski; Paweł Kubiński; Andrzej Lubiński
Journal:  Cardiovasc Drugs Ther       Date:  2018-04       Impact factor: 3.727

7.  Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

Authors:  Michal M Farkowski; Aleksander Maciag; Rafal Dabrowski; Mariusz Pytkowski; Ilona Kowalik; Hanna Szwed
Journal:  Trials       Date:  2012-09-11       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.